Baselga - Financial disclosure in oncology leaves ‘room for standardization'
Reporting of financial ties to industry has become an increasingly contentious, ethically murky area in both oncologic research and clinical practice. In 2018, prominent...
View ArticleBaselga - Sloan Kettering Paid $1.5 Million Severance to a Cancer Doctor...
Memorial Sloan Kettering Cancer Center gave Dr. José Baselga a payout after he resigned under fire in 2018 over his ties to health care companies.
View Article'One of the True Giants in Oncology,' Jose Baselga Dies at 61
The internationally reknown oncologist was involved in the development of several drugs for the treatment of breast cancer. Originally from Barcelona, he returned home on...
View ArticleJosé Baselga, head of oncology R&D for AstraZeneca and ‘true change-maker,'...
Prominent cancer researcher José Baselga, MD, PhD, FASCO, who served as head of oncology research and development for AstraZeneca, has died at age 61 years, the company...
View ArticleJosé Baselga, Who Advanced Breast Cancer Treatments, Dies at 61
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at AstraZeneca.
View Article
